pimozide has been researched along with vasoactive intestinal peptide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Stobie, KM; Weick, RF | 1 |
| Dominguez, JR; López, FJ; Negro-Vilar, A; Sánchez-Franco, F | 1 |
2 other study(ies) available for pimozide and vasoactive intestinal peptide
| Article | Year |
|---|---|
Vasoactive intestinal peptide inhibits luteinizing hormone secretion: the inhibition is not mediated by dopamine.
Topics: Animals; Female; Gonadotropin-Releasing Hormone; Hypothalamus; Luteinizing Hormone; Ovariectomy; Pimozide; Pituitary Gland; Rats; Rats, Inbred Strains; Receptors, Dopamine; Vasoactive Intestinal Peptide | 1989 |
Role of dopamine and vasoactive intestinal peptide in the control of pulsatile prolactin secretion.
Topics: Animals; Domperidone; Dopamine; Haloperidol; Immunization, Passive; Male; Periodicity; Pimozide; Prolactin; Rats; Rats, Inbred Strains; Receptors, Dopamine; Vasoactive Intestinal Peptide | 1989 |